主持
北京大学第一医院
14:30-14:55
Engineered anti-PDL1 with IFNα targets both immunoinhibitory and activating signals in the liver to break HBV immune tolerance.
首都医科大学附属北京同仁医院
15:00-15:25
Single-cell RNA sequencing reveals intrahepatic and peripheral immune characteristics related to disease phases in HBV-infected patients.
中国人民解放军总医院第五医学中心
15:25-15:30
DISCUSSION